Current state and prospective of the Korean medical research on the cancer metabolism |
Chung, Tae-Wook
(Korean Medical Research Center for Healthy Aging, Pusan National University)
Kim, Eun-Yeong (Korean Medical Research Center for Healthy Aging, Pusan National University) Choi, Hee-Jin (Korean Medical Research Center for Healthy Aging, Pusan National University) Choi, Hee-Jung (Korean Medical Research Center for Healthy Aging, Pusan National University) Ha, Ki-Tae (Korean Medical Research Center for Healthy Aging, Pusan National University) |
1 | Jung, K.W., et al., Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat, 2015. 47(2): p. 127-41. DOI |
2 | Yaswen, P., et al., Therapeutic targeting of replicative immortality. Semin Cancer Biol, 2015. |
3 | Batra, S., et al., Cancer Metabolism as a Therapeutic Target. Oncology (Williston Park), 2013. 27(5). |
4 | Koppenol, W.H., P.L. Bounds, and C.V. Dang, Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer, 2011. 11(5): p. 325-37. DOI |
5 | Zhou, J., et al., Research progress on synergistic anti-tumor mechanisms of compounds in traditional Chinese medicine. J Tradit Chin Med, 2014. 34(1): p. 100-5. DOI |
6 | Wang, C.Y., X.Y. Bai, and C.H. Wang, Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. Am J Chin Med, 2014. 42(3): p. 543-59. DOI |
7 | Lee, J.H., et al., Review of tumor dormancy therapy using traditional oriental herbal medicine. J Pharmacopuncture, 2013. 16(1): p. 12-20. DOI |
8 | Breusch, F.L., Citric Acid Cycle; Sugar and Fatbreakdown in Tissue Metabolism. Science, 1943. 97(2526): p. 490-2. DOI |
9 | Keijer, J. and D.A. van Dartel, Reprogrammed metabolism of cancer cells as a potential therapeutic target. Curr Pharm Des, 2014. 20(15): p. 2580-94. DOI |
10 | Huang, D., C. Li, and H. Zhang, Hypoxia and cancer cell metabolism. Acta Biochim Biophys Sin (Shanghai), 2014. 46(3): p. 214-9. DOI |
11 | Brahimi-Horn, M.C. and J. Pouyssegur, Hypoxia in cancer cell metabolism and pH regulation. Essays Biochem, 2007. 43: p. 165-78. DOI |
12 | Palmer, C.S., et al., Glucose metabolism regulates T cell activation, differentiation, and functions. Front Immunol, 2015. 6: p. 1. |
13 | Semenza, G.L., HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev, 2010. 20(1): p. 51-6. DOI |
14 | Brahimi-Horn, M.C., G. Bellot, and J. Pouyssegur, Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev, 2011. 21(1): p. 67-72. DOI |
15 | Fan, J., et al., Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells. Mol Cell Biol, 2011. 31(24): p. 4938-50. DOI |
16 | Vander Heiden, M.G., L.C. Cantley, and C.B. Thompson, Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009. 324(5930): p. 1029-33. DOI |
17 | Hitosugi, T., et al., Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell, 2011. 44(6): p. 864-77. DOI |
18 | Farwell, M.D., D.A. Pryma, and D.A. Mankoff, PET/CT imaging in cancer: current applications and future directions. Cancer, 2014. 120(22): p. 3433-45. DOI |
19 | Tennant, D.A., R.V. Duran, and E. Gottlieb, Targeting metabolic transformation for cancer therapy. Nat Rev Cancer, 2010. 10(4): p. 267-77. DOI |
20 | Le, A., et al., Conceptual framework for cutting the pancreatic cancer fuel supply. Clin Cancer Res, 2012. 18(16): p. 4285-90. DOI |
21 | Wang, Z., et al., Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer. PLoS One, 2013. 8(2): p. e56631. DOI |
22 | Wang, H., et al., Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1alpha and glycolysis, by inhibiting PI3K/Akt signaling pathway. Mol Carcinog, 2014. 53 Suppl 1: p. E107-18. DOI |
23 | Gao, J.L. and Y.G. Chen, Natural compounds regulate glycolysis in hypoxic tumor microenvironment. Biomed Res Int, 2015. 2015: p. 354143. |
24 | Center, K.B.-E.R., 2014 Biopharmaceutics Trend Repot. 2014. |
25 | Butler, E.B., et al., Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance. Cancer Res, 2013. 73(9): p. 2709-17. DOI |
26 | Ajani, J.A., et al., Cancer Stem Cells: The Promise and the Potential. Semin Oncol, 2015. 42 Suppl 1: p. S3-S17. |